Stevens-Johnson syndrome caused by indinavir

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 6, 1998, Pages 634-635

  Teira, Ramon ^a   Zubero, Zuriñe ^a   Muñoz, Josefa ^a   Baraia Etxaburu, Josu ^a   Santamaria, Juan Miguel ^a  

^a HOSPITAL DE BASURTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INDINAVIR; PROTEINASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; STEVENS JOHNSON SYNDROME;

ADULT; ANTI-HIV AGENTS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; MALE; STEVENS-JOHNSON SYNDROME;

EID: 0032457215     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549850161322     Document Type: Article

References (6)

1. Rzany B, Mockenhaupt M, Stocker U, Hamouda O, Schopf E. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany. Arch Dermatol 1993; 129: 1059.
2. Teira R, Virosta M, Zubero Z, Muñoz J, Santamaría JM. The safety of pyrimethamine-sulfadoxine for the prophylaxis of Pneumocystis carinii pneumonia in patients infected with HIV. Scan J Infect Dis 1997; 29: 595-6.
3. Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247-54.
4. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stern RS, Anderson T, Auquier A, Bastuji-Garin S, Correia O, Locati F, Mockenhaupt M, Paoletti C, Shapiro S, Shear N, Schöpf E, Kaufman DW. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600-7.
5. Fazal BA, Turett GS, Justman JE, Hall G, Telzak EE. Stevens-Johnson syndrome induced by treatment with acyclovir. Clin Infect Dis 1995; 21: 1038-9.
6. Parneix-Spake A, Bastuji-Garin S, Levy Y, Dubreuil-Lemaire ML, Roujeau JC. Didanosine as probable cause of Stevens-Johnson syndrome. Lancet 1992; 340: 857-8.